Areas of Work Regulatory System Strengthening Access and Rational Use Blood, Radiological and Pharmaceutical Services.

Slides:

Advertisements

Similar presentations

Technical cooperation with countries Technical Cooperation for essential drugs and traditional medicines September 2005.

Advertisements

World Health Organization

THE STRATEGIC COUNCIL LEADERSHIP TRUST AND ENGAGEMENT NEW FUNDING SOURCES AND NEW DELIVERY VEHICLES Appendix 1 NEW FUNDING SERVOURCES AND NEW DELIVERY.

V Conference of the Pan American Network for Drug Regulatory Harmonization (PANDRH) 17 – 19 November 2008 Buenos Aires Argentina Beverly Reynolds CARICOM.

Panamerican Health Organization 1 James Fitzgerald Senior Advisor, Medicines and Health Technologies PAHO/WHO Washington Affordable, Appropriate Access.

PROCUREMENT & DISTRIBUTION INTEREST GROUP Autumn Symposium 2007

Access to HIV/AIDS, Tuberculosis and Malaria Medicines. WHO/UNICEF Technical Briefing Seminar on Essential Medicines Policies. Geneva, 18 – 22 September.

Application of an International Reference Price List to National Medicines Procurement Tenders Bada Pharasi, Gavin Steel, Jean-Pierre Sallet, SPS, Management.

African Business Leaders on Health GBC Conference on TB, HIV-TB Co-infection & Global Fund Partnership Johannesburg, October 2010 Technical Assistance.

Advancing environmental sustainability in WHO/PAHO and in the health sector.

Importance of Health Information Systems Information explosion during 1990s  It is estimated that in the next 50 years, the amount of knowledge currently.

Tamyka Steinbeck Laura Barlow Thomas Caddell Brittany DeWitt.

Wilbert Bannenberg SARPAM

Chapter 13 Research and Metrics McGraw-Hill/Irwin Purchasing and Supply Management, 13/e © 2006 The McGraw-Hill Companies, Inc., All Rights Reserved.

Medicines Transparency Alliance01/10/2015 Availability of Medicines Anita Wagner Harvard Medical School & WHO Collaborating Center in Pharmaceutical Policy.

Corporate Governance in the Caribbean Environment “The Caribbean Corporate Governance Forum” Trevor E Blake General Manager – ECSE.

The Regional Platform for Access and Innovation for Health Analía Porrás Medicines and Health Technologies (HSS/MT) Health Systems based on Primary Health.

Summary from the Economics Track With thanks to all track participants, presenters, rapporteurs, moderators and organizers.

RHSC Meeting Kampala, May 2010 Quality for Medicines The Global Fund approach Sophie Logez Manager, QA and Data Quality Pharmaceutical Management.

Paula Munderi Department of Essential Drugs and Medicines Policy World Health Organization Access to essential medicines for HIV/AIDS - update on WHO activities.

Social Protection and Employment Generation: Comments on the joint OAS-ILO- ECLAC document Vinícius Pinheiro (ILO) Rio de Janeiro, 11/30/2010.

ACCESS TO MEDICINES - POLICY AND ISSUES

Regulatory Institutions in Turkey. Regulatory Institutions Central Bank of Turkey Banking Supervision and Regulatory Institutions Capital Markets Board.

Existing Challenges – POC Introduction Lab Technical Working Group Jason Williams, Principal Laboratory Advisor, SCMS January 20-21, 2013.

Policy track summary ICIUM 2011 – 18 Nov Policy track topics 1.The pharmaceutical policy process 2.Quality and safety of medicines in LMIC 3.Policy.

Brussels, May 2008MDA Update, RHSC membership meeting Market Development Approaches Working Group Update November 2007 – May 2008 Ben Light MDAWG Leader,

Overview of the Global Fund Procurement and Supply Management Issues Workshop for LAC Consultants th July 2009 Pharmaceutical Management Advisory.

Latin America Class 3. Why did Latin America persist with ISI??? Perspective 1: –Political influence of land-based oligarchy and their foreign allies.

SARPAM Southern African Regional Programme for Access to Medicines and Diagnostics Presentation to Botswana TRIPS and Access to Medicines workshop 26 March.

1 Pharmaceutical System Strengthening: Is There a Need for a New Paradigm? Douglas Keene, PharmD, MHS ICIUM-3 Pre-Conference Session 14 November 2011.

Strengthening the impact of the WHO prequalification program April 28, 2007.

1 SADC POOLED PROCUREMENT STRATEGY FOR ESSENTIAL MEDICINES & HEALTH COMMODITIES AARTI PATEL: TA SADC PBP BOTSWANA NATIONAL TRIPS & IP WORKSHOP.

Philippe Duneton11 February 2009 Deputy Executive Secretary 5th Consultative Stakeholder Meeting UN Prequalification of Diagnostics, Medicines & Vaccines.

TBS 2008-H. Tata & M. Babaley Mapping and In-depth Assessment of Medicines Procurement and Supply Systems WHO Technical Briefing Seminar 17 th -21 st November.

Pan American Health Organization 1 PAHO Technology, Healthcare and Research Project of Essential Medicine and Biologicals Linking Technical Cooperation.

Supply Chain Management Purchasing/Inventory/Materials.

Challenges in WTO Accession —The case of Vietnam By Cristina Hernandez (UNDP-MPI Project VIE/02/009) World Bank Training Course “ Trade in Services and.

1 Vision: To be an agency producing outputs that contribute to optimal efficiency of the Indonesian Universal Health Coverage (UHC) Mission: To ensure.

MONITORING MEDICINE AVAILABILITY AND PRICES IN UGANDA By Denis Kibira HEPS Uganda.

Zafar Mirza IPC 11 th Dec 2015, Geneva National Strategy for Pharmaceutical Manufacturing Development in Ethiopia developing industry to improve access.

TBS Meeting Geneva, November 2010 Procurement and Supply Management Policies WHO/UNICEF Technical Briefing Seminar on Essential Medicines Policies, November.

Towards a Central Africa Trade Facilitation Strategy: Customs union and Policy Dialogue BBL – September 29 th 2011.

Implementation of TRIPS Flexibilities In National IP Legislation For Strengthening Access To Medicines In Swaziland Workshop with MOH and stakeholders,

3rd WHO Prequalification Stakeholders Meeting :Diagnostics 3rd Stakeholders Meeting on Prequalification Geneva, 4th February 2008 Update on Prequalification.

Strategic Objective 4 To promote the exchange of experiences and regulatory knowledge between NRAs inside and outside PANDRH“ Lessons learned from international.

Round Table: Future challenges for PANDRH CARICOM Perspective.

Impact: promoting the dissemination & utilization of research findings 45th Session of the ACHR/CAIS Hamilton, Canada October 17 – 19, 2012 Tomás Pantoja,

International Monetary Fund. INTERNATIONAL MONETARY FUND What IMF do The IMF promotes international monetary cooperation and exchange rate stability,

Advancing Partnerships for Universal Health Coverage HANSHEP Workshop Dr. Rehana Ahmed 9 July 2015 Nairobi 1.

Human Rights and Access to Medicines Sean Flynn AU, Washington College of Law Abuja, Nigeria, November 2008.

Economics of Pharmaceutical Regulation in the Mediterranean: the case of Spain and Italy Joan Costa Font LSE.

Taxonomy of Strategies

Wilbert Bannenberg SARPAM

WHO Meeting of Interested Parties

Review of integrated PSM resources and tools and introduction to group work Upjeet Chandan ICCM FTT 17th February 2016.

The Jobs Group MANDATE AND Work program Mary Hallward-Driemeier

GBM 489 Competitive Success/snaptutorial.com

GBM 489 Education Your Life-- gbm489.com ENV 340 STUDY.

World Health Organization

Wednesday 16 May 2018 Zagreb, Croatia

Vision, Mission, and Goals

Managing Procurement and Logistics of HIV/AIDS Drugs and Related Supplies Introduction and Overview May 30 to June 4, 2005 Abuja, Nigeria.

Access to HIV/AIDS Medicines The 3x5 strategy

Access to Essential Medicines

Title : Quality data for efficient management - lessons from the UNRWA Health Procurement Strengthening Project Abstract: Introduction :UNRWA has been.

Levison L, Laing RL, Waning B, Kaplan W

The International Marketing Imperative

Seventh Regional Public Procurement Forum, May , 2011

An Enabling Business Environment and A Strategic Collaborative Approach for Sustainable Quality Local Production Africa Pharma Conference 4-5 June 2019,

An Enabling Business Environment and A Strategy and Collaborative Approach for Sustainable Quality Local Production Africa Pharma Conference 4-5 June 2019,

Presentation transcript:

Areas of Work Regulatory System Strengthening Access and Rational Use Blood, Radiological and Pharmaceutical Services

Regulatory System Strengthening Systems approach/ Across all technologies. Contemplate the specificities off specific technologies Exchange of Information: REPs (regulatory exchange platform secure) Pan American Journal of Public Health: special issue (june 2016) PANDRH: new Strategic Plan, Conference :October 2016, MEX CRS: Caribbean Regulatory System Title of the Presentation2

Regulatory Strengthening: Assessment, monitor and evaluation

Access and Rationale Use New doc on developing a Pharmaceutical Policy Rational Use Strategy for PAHO MS Agreement with GF on Supply chain management strengthening: direct TC for target countries Title of the Presentation4

Growing Participation of Member States

SF: types of commodities and criteria for selection 6 WHO Essential Medicines Diagnostics Vector control Other Strategic Medicines Evidence- informed Cost- effectiveness Equity/ vulnerability Public Health impact

7 Pooling Demand / Reducing Price

EFAVIRENZ 600MG/ EMTRICITABINE 200MG/ TENOFOVIR 300MG and EFAVIRENZ 600MG/ LAMIVUDINE 300MG/ TENOFOVIR DISOPROXIL FUMARATE 300MG Supporting Expansion of Treatment and Care

SF Trends : Capitalization Account growth # Loans

Products with several competitive (multisource) alternatives Strategic Fund pools demand for countries, seek qualified generic/multisource sources, and lower price through improved competition. Products with supply issues due to lack of commercial interest Strategic Fund pools demand, and negotiates with suppliers to stabilize supply and the market. Strategic Fund facilitates supply of priority donations for neglected diseases. Products under patent protection (monopolies and/or oligopolies) Strategic Fund informs on price trends, and negotiate directly with suppliers. Strategic Fund supports/establishes the necessary linkages with country led negotiations to facilitate procurement. Collective Action to improve Access

Mercosur and associated countries price negotiations o Led by MS o Hep C manufacturers o Price for entire region, through SF Access and rational use of high cost and strategic medicines and other health technologies Title of the Presentation11